about
Cerebrospinal fluid may mediate CNS ischemic injury.Facing Time in Ischemic Stroke: An Alternative Hypothesis for Collateral FailureDynamics of neuroinflammation in the macrosphere model of arterio-arterial embolic focal ischemia: an approximation to human stroke patterns.Delayed graft function in the kidney transplantThe importance of early brain injury after subarachnoid hemorrhageSpreading Depression, Spreading Depolarizations, and the Cerebral VasculatureImprovement in myocardial function and coronary blood flow in ischemic myocardium after mannitolGlial and neuronal control of brain blood flowEscape of intraluminal platelets into brain parenchyma after subarachnoid hemorrhage.Neurophysiological, metabolic and cellular compartments that drive neurovascular coupling and neuroimaging signals.Delayed reperfusion deficits after experimental stroke account for increased pathophysiology.Pathogenesis of hypertensive retinopathy. An experimental study in the monkey.Experimental occlusion of the central artery of the retina. IV: Retinal tolerance time to acute ischaemia.Global and regional differences in cerebral blood flow after asphyxial versus ventricular fibrillation cardiac arrest in rats using ASL-MRIReperfusion is a more accurate predictor of follow-up infarct volume than recanalization: a proof of concept using CT in acute ischemic stroke patientsRestoration and maintenance of glomerular filtration by mannitol during hypoperfusion of the kidney.Animal models of ischemic stroke. Part two: modeling cerebral ischemia.Postischemic reperfusion causes smooth muscle calcium sensitization and vasoconstriction of parenchymal arteriolesThe Immune Response to Acute Focal Cerebral Ischemia and Associated Post-stroke Immunodepression: A Focused Review.Inhibition of Src phosphorylation reduces damage to the blood-brain barrier following transient focal cerebral ischemia in ratsDynamics of glomerular ultrafiltration in the rat. V. Response to ischemic injury.The contribution of chemoreceptor-network injury to the development of respiratory arrest following subarachnoid hemorrhage.Structural abnormalities in neuronesPeriventricular leucomalacia in neonates. Complications and sequelaeProtease activated receptor-1 mediates cytotoxicity during ischemia using in vivo and in vitro models.Effect of spinal cord compression on local vascular blood flow and perfusion capacityEndothelial superoxide production in the isolated rat heart during early reperfusion after ischemia. A histochemical studyNo-Reflow Phenomenon in Central Retinal Artery Occlusion: Incidence, Risk Factors, and Clinical ImplicationsMyocardial ischemia: the pathogenesis of irreversible cell injury in ischemiaThe role of cell swelling in ischemic renal damage and the protective effect of hypertonic soluteCombined spin- and gradient-echo perfusion-weighted imaging.Cerebral ischemia. III. Vascular changes.Glomerular mesangial and endothelial cell swelling following temporary renal ischemia and its role in the no-reflow phenomenonIschemic tissue injury.Prevention by chlorpromazine of ischemic liver cell death.Adenosine A3 receptor stimulation and cerebral ischemiaRepurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocyclineBiophysical properties and microfilament assembly in neutrophils: modulation by cyclic AMP.No-reflow phenomenon in the cerebral circulation of the gerbilIschaemic brain damage in the gerbil in the absence of 'no-reflow'.
P2860
Q24810607-F80B6878-4E3F-497D-A49E-2C56231BF55BQ26767318-C8178A4F-17B9-4007-8661-A70982FCA2E1Q26799846-C5925002-325C-48A8-B225-49478DBA23B1Q26824506-FDD0844B-0C73-40C3-AE1D-DBE28C667B76Q27028040-64EC8BE3-836A-465B-93C6-D649A58D0D9BQ28264417-6B8F2D31-0E58-4EC7-8D87-5E72D7EC1BBAQ28363676-AD2E4E12-4EBE-4475-9186-C57F7494B4ECQ29620058-676DE607-EF3C-459A-A2AA-2A241CEC220DQ30492969-E0AB554F-9483-48A2-B677-EE62EF55ABC5Q30610142-166CD63B-4FEA-4FBE-88BE-065927443A1CQ30649932-B5396277-01AD-412C-947F-4F2A4B4848B5Q33598535-097DD928-D05B-4002-8DFC-4F04BA47FEC5Q33652212-81CAC59F-E97B-43E6-B8CD-9A73E0E636F2Q33758192-DBB52A33-62AD-4CDF-98D3-1AEE7CCE151DQ34018711-40A86D22-59E3-4158-8030-59B9E864FF8DQ34070871-028ECDE0-059F-4BAD-AD72-673437BFD948Q34072182-71739FEC-D843-4B29-9F95-E65D14F7F76AQ34087786-8555C696-386F-42B7-8628-830AE1AC503DQ34237954-55399281-8369-43BB-886A-B55BC652D5C5Q34426899-94B931EB-DE40-4E30-8AB1-96C918DF6AF3Q34459315-B4F6D330-1901-485C-8250-8DD54289A3AFQ34666438-A440F363-84E1-4C09-8EC0-1B2B9802BDA8Q34864688-E5DF71D1-F608-4F23-B890-7792CA9B9805Q35151319-884F3D30-A580-413A-A7FE-216A706C2D4BQ35225903-BDAC2C2F-AA42-4C4B-A9C7-B16CEE65BE0DQ35287548-DE8F0D4C-FE50-4E12-9702-A1F91D5EB597Q35831156-1DA08C98-0EFE-4086-BB97-6221F487F153Q35850184-4194111E-AEC5-4A66-9A51-788A74E1F0C6Q35863648-4836CB92-76EE-42F1-95D7-51EBD80AC017Q35896956-B73C03B6-6FCA-42DD-ABAE-3D703D6718F4Q36031027-30FCA2D1-F518-4EB1-99DB-55BB7ADE329BQ36051424-8150EA0E-FF74-49F9-93CF-FA1E3CBFFC8AQ36077276-2346C07A-D540-4E45-8033-24DD9A469CB5Q36077544-54EEE7C5-2ADC-445A-825A-CEBF2361A539Q36077747-8F9A1763-8154-411E-9ABA-A4FA27C8CE1CQ36185246-7691B885-0AAB-4691-82EF-7D0308362BE6Q36514428-D230C410-973B-4788-8CCD-203BBD766477Q36530229-1D8B2B8C-B817-46B5-9DAD-52F1305FAB73Q37039948-644FD1E3-B4E2-4A31-9A78-A72614A59BB8Q37039998-281D9CA5-20F8-44DF-A8E2-7DBAEC323D03
P2860
description
1968 nî lūn-bûn
@nan
1968年の論文
@ja
1968年学术文章
@wuu
1968年学术文章
@zh-cn
1968年学术文章
@zh-hans
1968年学术文章
@zh-my
1968年学术文章
@zh-sg
1968年學術文章
@yue
1968年學術文章
@zh
1968年學術文章
@zh-hant
name
Cerebral ischemia. II. The no-reflow phenomenon.
@ast
Cerebral ischemia. II. The no-reflow phenomenon.
@en
type
label
Cerebral ischemia. II. The no-reflow phenomenon.
@ast
Cerebral ischemia. II. The no-reflow phenomenon.
@en
prefLabel
Cerebral ischemia. II. The no-reflow phenomenon.
@ast
Cerebral ischemia. II. The no-reflow phenomenon.
@en
P2093
P2860
P1476
Cerebral ischemia. II. The no-reflow phenomenon.
@en
P2093
P2860
P304
P407
P577
1968-02-01T00:00:00Z